Exhibtion/Conference

LAVA Liquid Embolic System have been made the clinical trials from Jan 2022 in Chinese hospitals. Till now, the 75 enrolled subjects (38 in the experimental group and 37 in the control group) were ...

Stroke is the most common clinical cerebrovascular disease with high disability and mortality rates. The treatment of stroke has been a major problem in neurosurgery for many years. In recent years...

We are excited and grateful to our local distributor in Turkey to promote NeuroSafe’s products with Lava TM Liquid Embolic System, Dredger TM Revascularization Device and Glutton TM Aspiration Cath...

The third meeting of "Interventional Oncology: Multidisciplinary Treatment Approach" was held at Divan Ankara Hotel in Turkey on 13-14 January 2023. This meeting was supported by Turkish leading co...

The LINNC conference is one of the most important neurointerventional conferences in the world. Every year, it attracts many clinical interventional neurologists and neurosurgeons from all over the...

In order to serve customers better and know more the local market, NeuroSafe team visited the local distributor in November 2022 in Turkey, and communicated in details with the doctors about the pr...

From May 30 to June 1 in2022, NeuroSafe Medical Co., Ltd. participated LINNC Paris 2022 in France. LINNC course is one of the most important international neurointerventional conferences, attractin...